New study collects data and samples to unlock mysteries of Drug-Induced liver damage

NCT ID NCT00360646

Recruiting now Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create a nationwide registry of 400 people who have experienced drug-induced liver injury (DILI). Researchers will collect medical information and biological samples like blood and DNA to build a resource for future studies. The goal is to better understand why some drugs cause severe liver damage in certain people. Participants must have had DILI since 1994 and be alive to join.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG INDUCED LIVER INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

drug-induced liver injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG INDUCED LIVER INJURY

Contacts and locations

Locations

Indiana University
RECRUITING

Indianapolis, Indiana, 46202-5111, United States
NIH Clinical Site
RECRUITING

Bethesda, Maryland, 20892, United States
Thomas Jefferson
RECRUITING

Philadelphia, Pennsylvania, 19141, United States
Univeristy of North Carolina at Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27599-7600, United States
University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109-0362, United States
University of Southen California
RECRUITING

Los Angeles, California, 90033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.